Navigation Links
Infinity Bio-Energy Ltd. Announces 2008 Annual General Meeting
Date:6/16/2008

SAO PAULO, Brazil, June 17 /PRNewswire/ -- Pursuant to the BDR offering and BOVESPA Listing announcement released on June 06, 2008, Infinity Bio-Energy Ltd. has called a shareholders' meeting on June 25, 2008 at 10:00 a.m (Sao Paulo time) to approve new bye-laws conforming to Novo Mercado Standards, the election and re-election of new board directors and the presentation of auditors' reports and financial statements and other matters.

Novo Mercado is a special segment of the Brazilian Stock Exchange (BOVESPA) which requires high standards of Corporate Governance. Notwithstanding that the BDR offering does not demand the same Corporate Governance levels, the Company intends to incorporate the Novo Mercado standards, being governed by the proposed bye-laws. In order to achieve these standards, the Company invites all shareholders to vote on the 2008 Annual General Meeting.

The agenda is described below:

Notice

YOU ARE HEREBY NOTIFIED that the 2008 Annual General Meeting of the Company
will be held at Rua Funchal, 418, 22nd floor, Sao Paulo, SP, Brazil, on:

June 25, 2008 at 10:00 a.m. (Sao Paulo time)

AGENDA

1. Elect a Chairman of the General Meeting, if necessary.

2. Read Notice convening this meeting.

3. Minutes of the last General Meeting to be read and confirmed.

4. Presentation of Auditors' Report and Financial Statements for the

year ended March 31, 2008.

5. Presentation of Directors' Report to the Shareholders.

6. Appoint BDO as Auditor of the Company until the close of the next

Annual General Meeting and authorize the Board of Directors to

determine the remuneration of the Auditor.

7. Consider the election of Eduardo Bom Angelo, Alberto Mendes Tepedino

and Dimitri Marriette Henri Pauwels as Class III Directors, and

authorize them to appoint Alternate Directors as and when they deem

fit.

8. Consider the re-election of John Walter and Dominic DiMarco as Class

II Directors, and authorize them to appoint Alternate Directors as

and when they deem fit.

9. Consider to redesign Andrew Lipman and Sergio Thompson-Flores as

Class II Directors, and authorize them to appoint Alternate

Directors as and when they deem fit.

10. Consider that the fees payable to the Directors will be determined

by the Compensation Committee.

11. Consider and, if thought fit, approve the recommendation of the

Board of Directors to amend the existing Bye-Laws of the Company in

the manner specified in the blacklined version of the Bye-Laws, to

be effective upon and subject to consummation of the offer of the

Brazilian DRs.

12. Consider any other business, which may properly come before the

meeting.

The proxy and amended bye-laws have been sent to the shareholders and are also available on the Company's website at http://www.infinitybio.com.br.


'/>"/>
SOURCE Infinity Bio-Energy Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
2. EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board
3. Haemonetics Announces Launch of Faster Plasma Collection Protocol
4. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
5. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
6. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
7. Villa St. Benedict Announces New Web Site
8. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
9. Indevus Announces Management Changes
10. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
11. Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017   Pulmatrix, Inc . (NASDAQ: ... developing innovative inhaled therapies to address serious pulmonary diseases, ... infections in the lungs of CF patients, PUR1900, has ... by the U.S. Food & Drug Administration. ... to speed the development of novel drugs against important ...
(Date:1/17/2017)...  Only nine percent of U.S. consumers believe pharmaceutical ... 16 percent believe health insurance companies do, according to ... of U.S. adults believe health care providers (such as ... hospitals (23%). "We are in the midst ... , vice president of reputation management and public affairs ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Pono ... balanced, peaceful and healthy lifestyle, announced today the official launch of its much-anticipated Pono ... the mind. , In development for over a year, the patented Pono ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, ... recently announced a collaboration with the Heidelberg University Hospital and the German Cancer ... preparation, following the company’s successful launch of its CATS (Capture and Amplification ...
Breaking Biology Technology:
(Date:12/16/2016)... -- Research and Markets has announced the addition of ... 2021" report to their offering. ... The biometric vehicle access system market, in ... 14.06% from 2016 to 2021. The market is estimated to be ... Million by 2021. The growth of the biometric vehicle access system ...
(Date:12/15/2016)... , Dec 15, 2016 ... Research and Markets has announced the addition ... offering. The report forecasts the global military biometrics market ... The report has been prepared based on an in-depth market ... and its growth prospects over the coming years. The report also includes ...
(Date:12/12/2016)... -- Researchers at Trinity College, Dublin, are opening up ... material with Silly Putty. The mixture (known as "G-putty") ... sense pulse, blood pressure, respiration, and even the ... The research team,s findings were published Thursday in ... Due ...
Breaking Biology News(10 mins):